EVENT PREVIEW
experience in peptide manufacturing, Peptisyntha provides expertise in the process design, scale-up and commercial manufacture of peptides. Employing proprietary peptide synthesis technologies, Peptisyntha develops cost-effective processes for all types of peptides, including the most challenging sequences, and manages their cGMP manufacture. From solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS) or hybrid combinations (SPPS-LPPS), the company will design the best manufacturing process for customers’ projects.
Saltigo (Stand 8F17) is a globally operating custom manufacturer, providing services in two business lines, Pharma, and Agro- & Fine Chemicals. Saltigo combines the flexibility of a mid-size company with the financial stability of a global player. The business consists of 90 per cent custom manufacturing services and 10 per cent multi-customer products. With a comprehensive set of services ranging from process development to pilot-scale operations and ultimately full-scale manufacturing, including special services such as analytics and registration support, Saltigo serves its worldwide customers throughout the entire life cycle of their products in accordance with national and international regulations and the principles of sustainable development.
Solvias (Stand 8F55) offers large capacity and extensive know-how for analytical and chemical development. With its services, products and technologies, Solvias provides integrated solutions to the pharmaceutical and biopharmaceutical industry worldwide. The company’s portfolio covers analytical services (E+L studies, method development, stability studies, QC analysis), biopharmaceutical analysis, solid-state services (polymorphism, salts and crystallization), chemical development and API manufacturing, high- throughput catalysis screening and ligand supply. Solvias has more than 250 highly qualified employees located in Kaiseraugst near Basel, Switzerland.
Bachem (Stand 5F16) is an independent, technology-based, public biochemicals company providing a full service to the pharmaceutical and biotech industry. The company is specialised in the process development and manufacture of peptides and small organic molecules as APIs, as well
18 sp2 Inter-Active September/October 2012
as innovative biochemicals for research purposes. It has more than 40 years of experience in peptide research, extensive know-how in peptide chemistry and organic synthesis, providing technology leadership; and efficient manufacturing processes, providing cost leadership. With headquarters in Bubendorf, Switzerland and affiliates in Europe and the USA, Bachem works on a global scale and holds a leading position in the field of peptides.
Catalent (Stand 10C06) offers services from drug and biologic development to delivery technologies to clinical and commercial supply. As a leading global drug development and delivery partner, the company has strong expertise and a broad choice of drug delivery technologies to help customers deliver more molecules to market faster, solve bioavailability challenges, enhance therapeutic profiles, optimise dose forms and provide global, reliable supply.
PolyPeptide Group (Stand 9H56) specialises in large-scale industrial manufacture of peptide-based active pharmaceutical ingredients (APIs) for human and veterinary therapeutic applications. The company offers custom development, protein purification, research-grade catalogue peptides, custom GMP manufacturing of proprietary peptides and GMP production of generic peptides such as ACTH (corticotropin), bivalirudin, calcitonin, carbetocin, deslorelin, desmopressin, eptifibatide, exenatide, felypressin, gonadorelin, lanreotide, leuprolide, octreotide, oxytocin, PTH (1-34), somatostatin, triptorelin and vasopressin. It has extensive experience in regulatory compliance and its manufacturing conforms to cGMP and ICH guidelines. PolyPeptide Group includes laboratories and manufacturing facilities in Denmark, Sweden, France, the USA and India.
AMRI (Stand 6C09) is a global contract research and manufacturing organisation that supplies services and technologies supporting the discovery and development of pharmaceutical products and the manufacturing of API and drug product for existing and experimental new drugs. For more than 21 years, AMRI has demonstrated its adaptability to respond to changes in the pharmaceutical and biotechnology industries. The company’s experience, its track record of success, and locations in the USA, Europe and Asia now provide customers with SMARTSOURCING™, a full range of value- added opportunities providing more success at all stages of the pipeline.
Meet Andrew Pert of UBM Live Pharma
Andrew Pert has been appointed as the new Brand Director for CPhI, ICSE, P-MEC and InnoPack for Europe, Japan, South America and South East Asia. He joins the Pharma team with more than twelve years in B2B media experience.
He started his career in B2B publishing with Reed Business Information working on a portfolio of products that included magazines, digital publishing, exhibitions, awards and conferences. When he relocated to the United Arab Emirates in 2003, he took the role of Regional Director for UBM’s Built Environment division where he focused on developing and expanding conferences and exhibitions in the North Africa and Middle East markets.
In 2008, he was sponsored by UBM to obtain a Periodical Publishers Association (PPA) Diploma in Publishing and won the first-ever PPA Commercial Sales Director of the Year Award. He moved into his current role as Regional Director for the UBM Live Pharma portfolio of brands in early 2012 to focus on developing the Pharma portfolio’s digital strategy in collaboration with UBM Live’s Digital team.
Rockwood Lithium (Stand 4A38) is a leading supplier of lithium compounds such as butyllithium, lithium hydrides, lithium alkoxides, and lithium amides. As well as its expertise in this field of chemistry, the company also supplies other organometallic compounds such as Grignard reagents. In addition, Rockwood Lithium supplies cesium compounds as well as special metals. Headquartered in Germany, the company serves its customers with a worldwide network of sales offices as well as with production sites in Germany, North and South America, India and Taiwan. Since 2004, the company, known until this year as Chemetall Lithium, has been part of Rockwood Holdings, Inc.
Further information
www.cphi.com/linkedin www.linked.com/cphiww www.twitter.com/cphiww
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44